Intrexon | XON - Ingresos Por Ventas





Ventas Cambio Fecha
Agenus USD 34.2M 3.97M 2025-12
Alaunos Therapeutics USD 2K 2K 2025-03
Amgen USD 9.9B 340M 2025-12
Anika Therapeutics USD 30.62M 2.8M 2025-12
Arrowhead Research USD 264.03M 7.56M 2025-12
AstraZeneca USD 15.5B 313M 2025-12
Bristol-Myers Squibb USD 12.5B 300M 2025-12
Gilead Sciences USD 7.93B 130M 2025-12
GlaxoSmithKline GBP 8.62B 73M 2025-12
Heron Therapeutics USD 40.59M 2.38M 2025-12
Incyte USD 1.51B 140M 2025-12
Intrexon USD 717K 511K 2024-06
Karyopharm Therapeutics USD 30.54M 8.24M 2024-12
Ligand Pharmaceuticals USD 59.66M 55.8M 2025-12
MacroGenics USD 41.23M 31.61M 2025-12
MannKind USD 111.96M 29.83M 2025-12
Merck USD 16.4B 880M 2025-12
Novartis USD 13.86B 50M 2025-12
Rigel Pharmaceuticals USD 55.31M 18.47M 2024-09
Roche Holding CHF 15.65B 274.5M 2025-12
Sangamo BioSciences USD 356K 125K 2024-06
Thermo Fisher Scientific USD 12.21B 1.09B 2025-12
Veracyte USD 140.6M 8.7M 2025-12
Xencor USD 28.24M 7.24M 2025-12